Publication:
Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.

Simple item page
dc.contributor.authorO'Gorman, N
dc.contributor.authorWright, D
dc.contributor.authorPoon, L C
dc.contributor.authorRolnik, D L
dc.contributor.authorSyngelaki, A
dc.contributor.authorWright, A
dc.contributor.authorAkolekar, R
dc.contributor.authorCicero, S
dc.contributor.authorJanga, D
dc.contributor.authorJani, J
dc.contributor.authorMolina, F S
dc.contributor.authorde Paco Matallana, C
dc.contributor.authorPapantoniou, N
dc.contributor.authorPersico, N
dc.contributor.authorPlasencia, W
dc.contributor.authorSingh, M
dc.contributor.authorNicolaides, K H
dc.date.accessioned2023-01-25T09:42:56Z
dc.date.available2023-01-25T09:42:56Z
dc.date.issued2017-05-14
dc.description.abstractTo examine the diagnostic accuracy of a previously developed model for prediction of pre-eclampsia (PE) by a combination of maternal factors and biomarkers at 11-13 weeks' gestation. This was a prospective first-trimester multicenter study of screening for PE in 8775 singleton pregnancies. A previously published algorithm was used for the calculation of patient-specific risk of PE in each individual. The detection rates (DRs) and false-positive rates (FPRs) for delivery with PE In the study population, 239 (2.7%) cases developed PE, of which 17 (0.2%), 59 (0.7%) and 180 (2.1%) developed PE Assessment of a combination of maternal factors and biomarkers at 11-13 weeks provides effective first-trimester screening for preterm PE. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
dc.identifier.doi10.1002/uog.17399
dc.identifier.essn1469-0705
dc.identifier.pmid28067011
dc.identifier.unpaywallURLhttps://obgyn.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/uog.17399
dc.identifier.urihttp://hdl.handle.net/10668/10757
dc.issue.number6
dc.journal.titleUltrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
dc.journal.titleabbreviationUltrasound Obstet Gynecol
dc.language.isoen
dc.organizationHospital Universitario San Cecilio
dc.page.number751-755
dc.pubmedtypeEvaluation Study
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.rights.accessRightsopen access
dc.subjectBayes' theorem
dc.subjectfirst-trimester screening
dc.subjectmean arterial pressure
dc.subjectplacental growth factor
dc.subjectpre-eclampsia
dc.subjectpregnancy-associated plasma protein-A
dc.subjectpyramid of pregnancy care
dc.subjectsurvival model
dc.subjectuterine artery Doppler
dc.subject.meshAdult
dc.subject.meshBiomarkers
dc.subject.meshEurope
dc.subject.meshFemale
dc.subject.meshGestational Age
dc.subject.meshHumans
dc.subject.meshModels, Theoretical
dc.subject.meshPlacenta Growth Factor
dc.subject.meshPre-Eclampsia
dc.subject.meshPregnancy
dc.subject.meshPregnancy Trimester, First
dc.subject.meshPrenatal Diagnosis
dc.subject.meshProspective Studies
dc.subject.meshPulsatile Flow
dc.subject.meshRisk Assessment
dc.subject.meshSensitivity and Specificity
dc.subject.meshUterine Artery
dc.titleAccuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number49
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario San Cecilio

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía